“I struggle a bit with the cautionary outlook which doesn't gel with the operational opportunities mentioned above. Maybe it's an under promise, over deliver plan.”
This needs to be read along with the next paragraph re: Resolute review. It is hinting to me that most probably the company will be merged or sold or become a subsidiary of a large company - the stand alone operation is bit erratic in timing.
- Forums
- ASX - By Stock
- PET
- Ann: Appendix 4C Quarterly (Q2 2023) and Business Update
PET
phoslock environmental technologies limited
Add to My Watchlist
0.00%
!
2.5¢

Ann: Appendix 4C Quarterly (Q2 2023) and Business Update, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PET (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online